Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
Jun 24, 2020
Document Date
Jun 24, 2020
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/